Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLS-ILB-E710c in CIN2/3
NCT03274206Phase 2Unknown
- Sponsor
- MOA Life Plus Co. Ltd.
- Start
- Aug 2017
- Primary completion
- Aug 2020
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BLS-M07 in cervical intraepithelial neoplasia (CIN), sponsored by MOA Life Plus Co. Ltd.. Status: unknown.
02
Drugs
BLS-M07
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT03274206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03274206.